SCD and asthma: As expected, our results demonstrated that miR-192-5p inhibitor reduced the expression of ASCL3 and PPARα, while increasing the expression of FASN and SREBP1c, but these were all markedly reversed by SCD1 inhibitor, suggesting the regulation of lipid metabolism by miR-192-5p/SCD1 axis in CD4+T cells in asthma.